Contact Us  · Add to Favorite
Investor Relations Home
HomeInvestor Relations >  Investor Relations Home

Profile

China Nuokang Bio-Pharmaceutical Inc. is a leading, fully integrated, profitable biopharmaceutical company focused on researching, developing, manufacturing and marketing hematological and cardiovascular products. We sell a portfolio of fourteen products, which includes principal products Baquting®, a flagship hemocoagulase, and Aiduo®, a cardiovascular stress imaging agent. Our product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascula...

More »

More »Recent News

Date Title  
01/11/12 China Nuokang Bio-Pharmaceutical Inc. Broadens Product Portfolio by Acquiring Alpha Lipoic Acid Capsule for Diabetic Patients Add to Briefcase
12/23/11 China Nuokang Bio-Pharmaceutical Inc. Announces Results of 2011 Annual General Meeting Add to Briefcase
12/20/11 China Nuokang Bio-Pharmaceutical Inc. Appoints David Gao to Board of Directors Add to Briefcase
11/22/11 China Nuokang Bio-Pharmaceutical Inc. Announces Date of Annual General Meeting Add to Briefcase
11/17/11 China Nuokang Bio-Pharmaceutical Inc. Reports Third Quarter 2011 Financial Results Add to Briefcase
Stock Information
NKBP (Common Stock)
Exchange NASDAQ (US Dollar)
Price $2.96
Change (%) Stock is Up 0.11 (3.86%)
Volume 1,900
Data as of 02/22/12 1:14 PM ET
Minimum 20 minutes delay

Refresh quote
Investor Tools
Print Print Page
E-mail E-mail Page
Briefcase Shareholder Briefcase
Download Center Download Library
RSS RSS Feeds
E-mail Alerts E-mail Alerts
IR Contacts IR Contacts
Financial Tear Sheet Financial Tear Sheet
ICR, Inc.
In the U.S.:
Ashley De Simone
Phone: +1-646-277-1200
E-mail: Ashley.Desimone@icrinc.com

In China:
Wen Lei Zheng
Phone: +86-10-65837510
E-mail: WenLei.Zheng@icrinc.com

Nuokang's Consultant Team
Steven Duan
Phone: +86-24-24696037
COPYRIGHT © 2012 ALL RIGHTS RESERVED BY NUOKANG MEDICINE
Address : No.18, Nanpingdong Road, Hunnan District, Shenyang Liaoning Province, China